Hispanics and Diabetes People with Hispanic or Latino backgrounds are at higher risk for developing type 2 diabetes than non-Hispanic Caucasians. This is a fact that researchers have long known. However, most research has looked at this group as a whole,…
5 Barriers you’ll Have to Face while Diversifying Clinical Trials
Minority participation in clinical trials is an important topic in public health discussions. This representation touches on issues of equality and the elimination of disparities, which are core values of the field. The FDA Safety and Innovation Act introduced in 2012,…
Clinical Trials Diversity – More Minorities Needed to Make Research Relevant to All
Minorities, in fact, account for fewer than 10 percent of patients enrolled in clinical trials, according to the National Institutes of Health (NIH) National Institute on Minority Health and Health Disparities. Today, Wilkins brings together academic researchers and community members to…
Clinical Research in Ecuador | Diversity in Hispanic Community Involvement
Why Is Diversity Important? FDA Action Plan In 2012 the Food and Drug Administration Safety and Innovation Act was published. Most of this FDA Action plan is based to encourage researchers to include safety and effectiveness data by demographic subgroups, including…
How to boost Hispanics’ participation in clinical trials? Relate to them, study shows
Hispanic cancer patients rarely participate in clinical trials, but researchers want to tailor a Spanish DVD to help change this. To create a relevant educational tool, Moffitt Cancer Center researchers investigated why awareness of and participation in trials are so low…
Minority Inclusion in Clinical Trials: When Diversity Priorities Show
Beyond the critical need for securing more study volunteers across the board in clinical trials, a popular concern in all areas of clinical research is achieving inclusion in clinical trials and promoting diversity. Whether in medical journals, popular press, social media,…